Items where authors include "Macleod, T."

Article

David, P., Macleod, T., Altaie, A. orcid.org/0000-0002-9203-1490 et al. (16 more authors) (2025) Augmentation of immunothrombosis as a key mechanism underlying JAK inhibition associated hypercoagulability in rheumatoid arthritis. Annals of the Rheumatic Diseases. ISSN 0003-4967 (In Press)

Abacar, K., De Marco, G. orcid.org/0000-0003-2406-161X, Weddell, J. et al. (10 more authors) (2025) Late-Onset Spondylarthritis Presenting as Glucocorticoid-Resistant Polymyalgia Rheumatica: A hitherto underappreciated entity where TNF or IL-17 Blockade may have a Therapeutic Role. Arthritis & Rheumatology. ISSN 2326-5191 (In Press)

Giryes, S. orcid.org/0000-0002-4105-3550, Wong, C., Bridgewood, C. et al. (12 more authors) (2025) Paradoxical Activation of Entheseal Myeloid Cells by JAK1 and TYK2 Inhibitors via IL10 Antagonism. Arthritis & Rheumatology. ISSN 2326-5191 (In Press)

Abacar, K., Macleod, T., Direskeneli, H. et al. (1 more author) (2025) Takayasu arteritis: a geographically distant but immunologically proximal MHC-I-opathy. The Lancet Rheumatology, 7 (4). e290-e302. ISSN 2665-9913

Abacar, K., Macleod, T., Direskeneli, H. et al. (1 more author) (2024) How underappreciated autoinflammatory (innate immunity) mechanisms dominate disparate autoimmune disorders. Frontiers in Immunology, 15. 1439371. ISSN 1664-3224

Berekmeri, A., Macleod, T., Hyde, I. et al. (5 more authors) (2024) Epidermal proteomics demonstrates Elafin as a psoriasis‐specific biomarker and highlights increased anti‐inflammatory activity around psoriatic plaques. Journal of the European Academy of Dermatology and Venereology. ISSN 0926-9959

David, P. orcid.org/0000-0003-0075-5895, Hen, O., Ben-Shabbat, N. et al. (4 more authors) (2024) Pronounced benefits of JAK inhibition with baricitinib in COVID-19 pneumonia in obese but not lean subjects. RMD Open, 10 (2). e004045. ISSN 2056-5933

Dean, N.J. orcid.org/0000-0002-0627-7081, Clifton, I.J., Salman, R. et al. (4 more authors) (2024) Anti-IL-5 biologics and rheumatoid arthritis: a single-centre 500 patient year exposure analysis. RMD Open, 9 (4). e003583. ISSN 2056-5933

McGonagle, D. orcid.org/0000-0001-7715-8226, David, P. orcid.org/0000-0003-0075-5895, Macleod, T. orcid.org/0000-0002-7903-2990 et al. (1 more author) (2023) Predominant ligament-centric soft-tissue involvement differentiates axial psoriatic arthritis from ankylosing spondylitis. Nature Reviews Rheumatology, 19. pp. 818-827. ISSN 1759-4790

Ganguly, P. orcid.org/0000-0003-1042-5910, Macleod, T., Wong, C. et al. (2 more authors) (2023) Revisiting p38 Mitogen-Activated Protein Kinases (MAPK) in Inflammatory Arthritis: A Narrative of the Emergence of MAPK-Activated Protein Kinase Inhibitors (MK2i). Pharmaceuticals, 16 (9). 1286. ISSN 1424-8247

Conference or Workshop Item

David, P., Macleod, T., Shi, Y. et al. (6 more authors) (2023) Tofacitinib accelerates in vitro clot formation and delays clot lysis in rheumatoid arthritis blood by enhancement of macrophage TLR4 mediated cytokine responses - A new angle on thrombosis with JAKi in rheumatology. In: American College of Rheumatology Convergence 2023, 10-15 Nov 2023, San Diego, USA.

Proceedings Paper

Macleod, T., Dubash, S., Hyde, I. et al. (9 more authors) (2024) P51 Plaque psoriasis patients with psoriatic arthritis demonstrate a reduced regulatory capacity for neutrophil elastase compared with plaque psoriasis patients without arthritis. In: British Journal of Dermatology. 10th International Congress, Psoriasis: From Gene to Clinic, 05-07 Dec 2024, London, UK. Oxford University Press (OUP) , iii40.